{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T17:29:53Z","timestamp":1791221393579,"version":"4.1.0"},"reference-count":40,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2019,1,22]],"date-time":"2019-01-22T00:00:00Z","timestamp":1548115200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"DOI":"10.3389\/fimmu.2018.03092","type":"journal-article","created":{"date-parts":[[2019,1,22]],"date-time":"2019-01-22T06:36:07Z","timestamp":1548138967000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":33,"title":["Do Antiretroviral Drugs Protect From Multiple Sclerosis by Inhibiting Expression of MS-Associated Retrovirus?"],"prefix":"10.3389","volume":"9","author":[{"given":"Elena","family":"Morandi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Radu","family":"Tanasescu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rachael E.","family":"Tarlinton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dumitru","family":"Constantin-Teodosiu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruno","family":"Gran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2019,1,22]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1038\/nri3871","article-title":"Immunopathology of multiple sclerosis","volume":"15","author":"Dendrou","year":"2015","journal-title":"Nat Rev Immunol."},{"key":"B2","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1038\/nrneurol.2016.187","article-title":"Interactions between genetic, lifestyle and environmental risk factors for multiple sclerosis","volume":"13","author":"Olsson","year":"2017","journal-title":"Nat Rev Neurol"},{"key":"B3","doi-asserted-by":"crossref","first-page":"7583","DOI":"10.1073\/pnas.94.14.7583","article-title":"Molecular identification of a novel retrovirus repeatedly isolated from patients with multiple sclerosis","volume":"94","author":"Perron","year":"1997","journal-title":"Proc Natl Acad Sci USA"},{"key":"B4","doi-asserted-by":"publisher","first-page":"e0172415","DOI":"10.1371\/journal.pone.0172415","article-title":"The association between human endogenous retroviruses and multiple sclerosis: a systematic review and meta-analysis","volume":"12","author":"Morandi","year":"2017","journal-title":"PLoS ONE"},{"key":"B5","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1023\/A:1024455415443","article-title":"The evolution, distribution and diversity of endogenous retroviruses","volume":"26","author":"Gifford","year":"2003","journal-title":"Virus Genes"},{"key":"B6","doi-asserted-by":"publisher","first-page":"201","DOI":"10.23736\/S0393-2249.16.02658-8","article-title":"Toll-like receptors are essential for the control of endogenous retrovirus expression in idiopathic nephrotic syndrome minerva","volume":"69","author":"Bergallo","year":"2017","journal-title":"Urol Nefrol"},{"key":"B7","doi-asserted-by":"crossref","first-page":"7636","DOI":"10.4049\/jimmunol.176.12.7636","article-title":"The envelope protein of a human endogenous retrovirus-W family activates innate immunity through CD14\/TLR4 and promotes Th1-like responses","volume":"176","author":"Rolland","year":"2006","journal-title":"J Immunol"},{"key":"B8","doi-asserted-by":"publisher","first-page":"721","DOI":"10.1002\/ana.23970","article-title":"Human endogenous retrovirus type W envelope protein inhibits oligodendroglial precursor cell differentiation","volume":"74","author":"Kremer","year":"2013","journal-title":"Ann Neurol."},{"key":"B9","doi-asserted-by":"publisher","first-page":"e80128","DOI":"10.1371\/journal.pone.0080128","article-title":"Human endogenous retrovirus protein activates innate immunity and promotes experimental allergic encephalomyelitis in mice","volume":"8","author":"Perron","year":"2013","journal-title":"PLoS ONE"},{"key":"B10","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1136\/jnnp-2014-307932","article-title":"HIV and lower risk of multiple sclerosis: beginning to unravel a mystery using a record-linked database study","volume":"86","author":"Gold","year":"2015","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"B11","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1007\/s13365-014-0260-8","article-title":"CNS demyelinating disorder with mixed features of neuromyelitis optica and multiple sclerosis in HIV-1 infection. Case report and literature review","volume":"20","author":"Delgado","year":"2014","journal-title":"J Neurovirol."},{"key":"B12","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1007\/s13365-015-0335-1","article-title":"Multiple sclerosis and HIV-1 infection: case report of a HIV controller","volume":"21","author":"Chin","year":"2015","journal-title":"J Neurovirol."},{"key":"B13","doi-asserted-by":"publisher","first-page":"504","DOI":"10.1007\/s13365-011-0054-1","article-title":"Multiple sclerosis typical clinical and MRI findings in a patient with HIV infection","volume":"17","author":"Gonzalez-Duarte","year":"2011","journal-title":"J Neurovirol."},{"key":"B14","doi-asserted-by":"publisher","first-page":"e110","DOI":"10.1111\/j.1468-1331.2011.03430.x","article-title":"Could antiretroviral drugs be effective in multiple sclerosis? a case report","volume":"18","author":"Maruszak","year":"2011","journal-title":"Eur J Neurol."},{"key":"B15","doi-asserted-by":"publisher","first-page":"640","DOI":"10.1007\/s13365-014-0288-9","article-title":"Multiple sclerosis remission following antiretroviral therapy in an HIV-infected man","volume":"20","author":"Chalkley","year":"2014","journal-title":"J Neurovirol"},{"key":"B16","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1016\/j.msard.2018.06.002","article-title":"A phase II baseline versus treatment study to determine the efficacy of raltegravir (Isentress) in preventing progression of relapsing remitting multiple sclerosis as determined by gadolinium-enhanced MRI: the INSPIRE study","volume":"24","author":"Gold","year":"2018","journal-title":"Mult Scler Relat Disord."},{"key":"B17","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1002\/ana.22366","article-title":"Diagnostic criteria for multiple sclerosis: 2010 revisions to the McDonald criteria","volume":"69","author":"Polman","year":"2011","journal-title":"Ann Neurol."},{"key":"B18","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1016\/j.jviromet.2009.05.024","article-title":"Novel reliable real-time PCR for differential detection of MSRVenv and syncytin-1 in RNA and DNA from patients with multiple sclerosis","volume":"161","author":"Mameli","year":"2009","journal-title":"J Virol Methods"},{"key":"B19","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1007\/978-1-4939-6655-4_3","article-title":"Establishment of EBV-Infected lymphoblastoid cell lines","volume":"1532","author":"Nagy","year":"2017","journal-title":"Methods Mol Biol."},{"key":"B20","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/0166-3542(92)90028-4","article-title":"Evaluation of multiple parameters of HIV-1 replication cycle in testing of AIDS drugs in vitro","volume":"17","author":"Volsky","year":"1992","journal-title":"Antiviral Res."},{"key":"B21","doi-asserted-by":"publisher","first-page":"979","DOI":"10.1002\/jmv.24418","article-title":"Testing anti-HIV activity of antiretroviral agents in vitro using flow cytometry analysis of CEM-GFP cells infected with transfection-derived HIV-1 NL4-3","volume":"88","author":"Frezza","year":"2015","journal-title":"J Med Virol."},{"key":"B22","doi-asserted-by":"publisher","first-page":"3432","DOI":"10.1128\/AAC.44.12.3432-3433.2000","article-title":"Antiretroviral agents inhibit infection of human cells by porcine endogenous retroviruses","volume":"44","author":"Powell","year":"2000","journal-title":"Antimicrob Agents Chemother"},{"key":"B23","doi-asserted-by":"publisher","first-page":"e44991","DOI":"10.1371\/journal.pone.0044991","article-title":"Expression and activation by Epstein Barr virus of human endogenous retroviruses-W in blood cells and astrocytes: inference for multiple sclerosis","volume":"7","author":"Mameli","year":"2012","journal-title":"PLoS ONE"},{"key":"B24","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1007\/978-3-319-22822-8_15","article-title":"EBV and Autoimmunity","volume":"390","author":"Ascherio","year":"2015","journal-title":"Curr Top Microbiol Immunol."},{"key":"B25","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1080\/13550280802448451","article-title":"The multiple sclerosis-associated retrovirus and its HERV- W endogenous family: a biological interface between virology, genetics, and immunology in human physiology and disease","volume":"15","author":"Dolei","year":"2009","journal-title":"J Neurovirol."},{"key":"B26","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1186\/1742-4690-6-104","article-title":"B cells and monocytes from patients with active multiple sclerosis exhibit increased surface expression of both HERV-H Env and HERV-W Env, accompanied by increased seroreactivity","volume":"6","author":"Brudek","year":"2009","journal-title":"Retrovirology"},{"key":"B27","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1186\/1742-4690-9-6","article-title":"HIV infection and HERV expression: a review","volume":"9","author":"van","year":"2012","journal-title":"Retrovirology"},{"key":"B28","doi-asserted-by":"publisher","first-page":"2659","DOI":"10.1097\/QAD.0000000000000477","article-title":"HIV Tat acts on endogenous retroviruses of the W family andthis occurs via Toll-like receptor 4: inference for neuroAIDS","volume":"28","author":"Uleri","year":"2014","journal-title":"AIDS"},{"key":"B29","doi-asserted-by":"publisher","first-page":"2417","DOI":"10.1097\/QAD.0b013e3282f14d64","article-title":"The replicative activity of human endogenous retrovirus K102 (HERV-K102) with HIV viremia","volume":"21","author":"Laderoute","year":"2007","journal-title":"AIDS"},{"key":"B30","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/j.jviromet.2006.03.029","article-title":"A new Real-Time-RT-PCR for quantitation of human endogenous retroviruses type K (HERV-K) RNA load in plasma samples: increased HERV-K RNA titers in HIV-1 patients with HAART non-suppressive regimens","volume":"136","author":"Contreras-Galindo","year":"2006","journal-title":"J Virol Methods"},{"key":"B31","doi-asserted-by":"publisher","first-page":"246","DOI":"10.3389\/fonc.2013.00246","article-title":"HERV-K(HML-2), the best preserved family of HERVs: endogenization, expression, and implications in health and disease","volume":"3","author":"Hohn","year":"2013","journal-title":"Front Oncol."},{"key":"B32","doi-asserted-by":"crossref","first-page":"17137","DOI":"10.1021\/bi9818927","article-title":"Functional characterization of the protease of human endogenous retrovirus K10: can it complement HIV-1 protease?","volume":"37","author":"Towler","year":"1998","journal-title":"Biochemistry"},{"key":"B33","doi-asserted-by":"publisher","first-page":"3923","DOI":"10.1038\/sj.onc.1208562","article-title":"Inhibition of endogenous reverse transcriptase antagonizes human tumour growth","volume":"24","author":"Sciamanna","year":"2005","journal-title":"Oncogene"},{"key":"B34","doi-asserted-by":"publisher","first-page":"2750","DOI":"10.1038\/sj.onc.1206354","article-title":"Exposure of normal and transformed cells to nevirapine, a reverse transcriptase inhibitor, reduces cell growth and promotes differentiation","volume":"22","author":"Mangiacasale","year":"2003","journal-title":"Oncogene"},{"key":"B35","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1038\/nri2524","article-title":"B cells in HIV infection and disease","volume":"9","author":"Moir","year":"2009","journal-title":"Nat Rev Immunol."},{"key":"B36","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1089\/aid.2008.0270","article-title":"Unreliable real-time PCR analysis of human endogenous retrovirus-W (HERV-W) RNA expression and DNA copy number in multiple sclerosis","volume":"25","author":"Garson","year":"2009","journal-title":"AIDS Res Hum Retroviruses"},{"key":"B37","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1186\/1742-4690-6-37","article-title":"Analysis of transcribed human endogenous retrovirus W env loci clarifies the origin of multiple sclerosis-associated retrovirus env sequences","volume":"6","author":"Laufer","year":"2009","journal-title":"Retrovirology"},{"key":"B38","doi-asserted-by":"publisher","first-page":"1313","DOI":"10.1089\/aid.2011.0297","article-title":"HIV type 1 infection up-regulates TLR2 and TLR4 expression and function in vivo and in vitro","volume":"28","author":"Hernandez","year":"2012","journal-title":"AIDS Res Hum Retroviruses"},{"key":"B39","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.jneuroim.2016.12.004","article-title":"Innate immune regulation of autoimmunity in multiple sclerosis: focus on the role of Toll-like receptor 2","volume":"304","author":"Hossain","year":"2017","journal-title":"J Neuroimmunol."},{"key":"B40","doi-asserted-by":"publisher","first-page":"457","DOI":"10.3389\/fimmu.2018.00457","article-title":"The Soluble form of toll-like receptor 2 is elevated in serum of multiple sclerosis patients: a novel potential disease biomarker","volume":"9","author":"Hossain","year":"2018","journal-title":"Front Immunol."}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fimmu.2018.03092\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,1,22]],"date-time":"2019-01-22T06:36:09Z","timestamp":1548138969000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fimmu.2018.03092\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,1,22]]},"references-count":40,"alternative-id":["10.3389\/fimmu.2018.03092"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2018.03092","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,1,22]]},"article-number":"3092"}}